The post Analyst Uses Fib and Regression Model to Predict When XRP May Hit $27 This Cycle appeared on BitcoinEthereumNews.com. Analyst EGRAG insists that XRP has not yet reached its top for this cycle, using Fibonacci targets and a regression model to project higher targets. Notably, XRP has witnessed volatility in recent months. After climbing to a new peak of $3.66 in July 2025 during the broader crypto market upsurge, it has since plunged below the $3 level amid a market-wide correction.  Despite this downturn, crypto analyst EGRAG believes XRP might not have reached its final peak for this cycle. He used a combination of linear regression models and Fibonacci targets to suggest XRP could soar as high as $27 before the current cycle ends. – Advertisement – XRP Last Leg After the Blue X Print In his recent analysis, EGRAG pointed to a recurring pattern he discovered while using the Lux Algo indicator on XRP’s weekly chart. According to data from EGRAG’s chart, the appearance of the Blue X symbol often signals a short-term profit-taking point.  XRP Lux Algo Premium Indicator However, he explained that in previous cycles, the Blue X sometimes misled traders into thinking a cycle top had arrived when it had not.  Specifically, what typically happens is that the Blue X prints when XRP hits a top, followed by a corrective phase to form a local bottom. However, after this correction, a strong upward push toward the true cycle peak emerges, which historically forms without any Blue X appearing at the top. The chart covers XRP’s entire price history from 2013 to 2025, separated into three main cycles. Cycle 1 ended around January 2018, while Cycle 2 concluded in April 2021, both topping out near the upper boundary of a long-term linear regression channel.  For context, in the 2017/2018 cycle, XRP printed the Blue X when it hit $0.3988 in May 2017. However, after the correction,… The post Analyst Uses Fib and Regression Model to Predict When XRP May Hit $27 This Cycle appeared on BitcoinEthereumNews.com. Analyst EGRAG insists that XRP has not yet reached its top for this cycle, using Fibonacci targets and a regression model to project higher targets. Notably, XRP has witnessed volatility in recent months. After climbing to a new peak of $3.66 in July 2025 during the broader crypto market upsurge, it has since plunged below the $3 level amid a market-wide correction.  Despite this downturn, crypto analyst EGRAG believes XRP might not have reached its final peak for this cycle. He used a combination of linear regression models and Fibonacci targets to suggest XRP could soar as high as $27 before the current cycle ends. – Advertisement – XRP Last Leg After the Blue X Print In his recent analysis, EGRAG pointed to a recurring pattern he discovered while using the Lux Algo indicator on XRP’s weekly chart. According to data from EGRAG’s chart, the appearance of the Blue X symbol often signals a short-term profit-taking point.  XRP Lux Algo Premium Indicator However, he explained that in previous cycles, the Blue X sometimes misled traders into thinking a cycle top had arrived when it had not.  Specifically, what typically happens is that the Blue X prints when XRP hits a top, followed by a corrective phase to form a local bottom. However, after this correction, a strong upward push toward the true cycle peak emerges, which historically forms without any Blue X appearing at the top. The chart covers XRP’s entire price history from 2013 to 2025, separated into three main cycles. Cycle 1 ended around January 2018, while Cycle 2 concluded in April 2021, both topping out near the upper boundary of a long-term linear regression channel.  For context, in the 2017/2018 cycle, XRP printed the Blue X when it hit $0.3988 in May 2017. However, after the correction,…

Analyst Uses Fib and Regression Model to Predict When XRP May Hit $27 This Cycle

Analyst EGRAG insists that XRP has not yet reached its top for this cycle, using Fibonacci targets and a regression model to project higher targets.

Notably, XRP has witnessed volatility in recent months. After climbing to a new peak of $3.66 in July 2025 during the broader crypto market upsurge, it has since plunged below the $3 level amid a market-wide correction. 

Despite this downturn, crypto analyst EGRAG believes XRP might not have reached its final peak for this cycle. He used a combination of linear regression models and Fibonacci targets to suggest XRP could soar as high as $27 before the current cycle ends.

– Advertisement –

XRP Last Leg After the Blue X Print

In his recent analysis, EGRAG pointed to a recurring pattern he discovered while using the Lux Algo indicator on XRP’s weekly chart. According to data from EGRAG’s chart, the appearance of the Blue X symbol often signals a short-term profit-taking point. 

XRP Lux Algo Premium Indicator

However, he explained that in previous cycles, the Blue X sometimes misled traders into thinking a cycle top had arrived when it had not. 

Specifically, what typically happens is that the Blue X prints when XRP hits a top, followed by a corrective phase to form a local bottom. However, after this correction, a strong upward push toward the true cycle peak emerges, which historically forms without any Blue X appearing at the top.

The chart covers XRP’s entire price history from 2013 to 2025, separated into three main cycles. Cycle 1 ended around January 2018, while Cycle 2 concluded in April 2021, both topping out near the upper boundary of a long-term linear regression channel. 

For context, in the 2017/2018 cycle, XRP printed the Blue X when it hit $0.3988 in May 2017. However, after the correction, the true cycle top emerged at $3.3 in January 2018. Also, in the 2020/2021 cycle, XRP saw the Blue X when it soared to $0.79 in November 2020. However, after the pullback, it rose to the true cycle top of $1.96 in April 2021.

XRP Blue X Prints in Previous Cycles | EGRAG Crypto

XRP Regression Channel and Fib Targets 

According to EGRAG, each cycle top happened near the upper boundary of a long-term linear regression channel. Notably, this channel features a red median line at its center and blue lines at the top and bottom marking two standard deviations away from the median. 

During both prior cycles, XRP’s price surged from the median line to the upper blue boundary before correcting sharply, creating the foundation for projecting the next cycle peak.

In this cycle, XRP saw the Blue X after it reached the $3.4 peak in January 2025. Now, amid the recent correction, XRP trades above the red median line but remains far below the upper blue band, which the model now projects to be near $27 by Oct. 13, 2025. 

Current Cycle Top | EGRAG Crypto

According to EGRAG, this aligns closely with Fibonacci extensions derived from both the 2017 and 2021 cycle peaks. The 2017 cycle top sits between the 1.618 and 1.88 Fibonacci levels at $20.46 and $49.44, while the 2021 peak aligns with the 2.414 and 2.618 levels at $23.49 and $34.08. The $27 target falls comfortably within both ranges.

Despite this optimistic projection, there is uncertainty. From its current level of around $2.72, XRP would need to rally more than 892% to reach $27. According to EGRAG, traders should lock in profits when possible.

DisClamier: This content is informational and should not be considered financial advice. The views expressed in this article may include the author’s personal opinions and do not reflect The Crypto Basic opinion. Readers are encouraged to do thorough research before making any investment decisions. The Crypto Basic is not responsible for any financial losses.

Source: https://thecryptobasic.com/2025/09/01/xrp-last-leg-analyst-uses-fib-and-regression-model-to-predict-when-xrp-may-hit-27-this-cycle/?utm_source=rss&utm_medium=rss&utm_campaign=xrp-last-leg-analyst-uses-fib-and-regression-model-to-predict-when-xrp-may-hit-27-this-cycle

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.719
$1.719$1.719
-1.54%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23